Atrial Fibrillation (Ablation) |
3-Oct 08:30 - 10:10 Hall 5G, Rm A Session 1 - New Technologies in AF Ablation Chairpersons: Akira Fujiki (Japan), Christian de Chillou (France), Sum-Kin Leung (Hong Kong)
1. Multi-electrode Ablation (Andrea Natale, USA)
2. Balloon Based Technologies (Gerhard Hindricks , Germany)
3. Contact Force Technologies (Karl-Heinz Kuck, Germany)
4. Imaging Technologies (3D ICE, MRI) (Douglas Packer, USA)
5. Novel Electrogram Mapping (Meleze Hocini , France)
3-Oct 13:50 - 15:30 Hall 5G, Rm A Session 2 - Ablation Strategies in AF Ablation Chairpersons: Kuan-Cheng Chang (Taiwan), Dong-Gu Shin (Korea), Mauricio Abello (Argentina)
1. Pulmonary Vein Isolation Alone Versus Expanded Ablation (David Burkhardt, USA)
2. Fractionated Electrogram Ablation (Shih-Ann Chen, Taiwan)
3. Linear Ablation (Yoshito Iesaka, Japan)
4. FIRM Ablation (Sanjiv Narayan, USA )
5. Hybrid Procedures (Chang-Sheng Ma, China)
4-Oct 08:30 - 10:10 Hall 5G, Rm A Session 3 - Strategies for Recurrent Atrial Arrhythmias After Ablation Chairpersons: Duncan Ho (Hong Kong), Hitoshi Hachiya (Japan)
1. Progression of Substrate (Yohei Sotomi, Japan)
2. Atrial Tachycardias (Young-Hoon Kim, Korea)
3. Energy Consideration (Jonathan S. Steinberg , USA)
4. Mitral Isthmus Ablation (Seiji Takatsuki, Japan)
5. Atrial Tachycardia Versus Atrial Fibrillation Recurrence (Prashanthan Sanders , Australia)
4-Oct 13:50 - 15:30 Hall 5G, Rm A Session 4 - AF Ablation: State of the Art in 2013 Chairpersons: Elaine Chau (Hong Kong), Toru Kawakami (Japan), Ahmad Fazil (Malyasia)
1. Techniques and Outcomes of Catheter Ablation of Paroxysmal AF (David Burkhardt, USA)
2. Techniques and Outcomes of Catheter Ablation of Long Standing Persistent AF (Robert Lemery, Canada)
3. Complications of AF Ablation (Yan-Zong Yang , China)
4. Anticoagulation Strategies During and Following AF Ablation (John Day, USA)
5. Indications for AF Ablation (Eric Prystowsky, USA)
5-Oct 08:30 - 10:10 Hall 5G, Rm A Session 5 - Anticoagulation/Stroke Prevention and Ablation Chairpersons: Kam-Tim Chan (Hong Kong), Sirin Apiyasawat (Thailand)
1. Novel Anticoagulants and Ablation (Anil Saxena, India)
2. Anticoagulation Before and Immediately After Ablation (Luigi Di Biase, USA)
3. Safety of Stopping Anticoagulation After Successful Ablation (Jian Chen, Norway)
4. Left Atrial Appendage Exclusion as an Adjunct to Ablation (Yat-Yin Lam, HK)
5. Ablation as Stroke Prevention (To be announced)
5-Oct 16:00 - 17:40 Hall 5G, Rm A Session 6 - Update in Complications of Atrial Fibrillation Ablation Chairpersons: Kwok-Keung Chan (Hong Kong), Jeong-Gwan Cho (Korea), Erika Maharani (Indonesia)
1. Pulmonary Vein Stenosis (Hugh Calkins, USA)
2. Atrial Esophageal Fistula (Davendra Mehta , USA)
3. Stroke Prevention (Jian-Zeng Dong, China)
4. Phrenic Nerve Damage and Balloon Technologies (Wyn Davies, UK)
5. Perforation and Tamponade (Michifumi Tokuda, Japan) |
Atrial Fibrillation (Device) |
3-Oct 16:00 - 17:40 Rm 426 Session 1: Monitoring AF by Implantable Devices – Why and How? Chairpersons: Man-Chun Choi (Hong Kong), Piya Kasemsuwan (Thailand)
1. Ongoing and Future Trials on AF Monitoring by Implantable Devices (Jeff Healey, Canada)
2. AF Monitoring after Pulmonary Vein Isolation: Why, How, and Which Study Results? (Shashidhar, India)
3. AF Monitoring for Stroke Prevention: Who, How, and Which Study Results? (Chu-Pak Lau, HK)
4. Remote AF Monitoring: Implications for Oral Anticoagulation (Gregory Lip , UK)
5. Trouble-Shooting: Appropriate or Inappropriate AF Detection? (Carsten Israel , Germany)
4-Oct 10:40 - 12:20 Hall 5G, Rm A Session 2: AF in Patients with Pacemakers and/or ICDs: What Have We Learned? Chairpersons: Kee-Joon Choi (Korea), Maria Belen O. Carisma (Philippines), Chris KY Wong (Hong Kong)
1. Implantable Loop Recorders for AF Monitoring: Techniques and Results (Yi-Gang Li , China)
2. AF in Pacemaker Patients: Preventive Pacing and Atrial ATP (John Ip, USA)
3. AF in ICD Patients: From Inappropriate Shocks to Internal Cardioversion (Luigi Padeletti, Italy)
4. Where to Implant the Atrial Lead for AF Prevention? (Chun-Chieh Wang, Taiwan)
5. AF in CRT Patients: What Should Be Done? (David Benditt, USA) |
Atrial Fibrillation (Drug) |
3-Oct 10:40 - 12:20 Hall 5G, Rm A Session 1 - Practical Aspects on Stroke Prevention in Atrial Fibrillation - What to Do? Chairpersons: Ton-That Minh (Vietnam), Marcellus Francis Ramirez (Philippines), Rungroj Krittayaphong (Thailand)
1. My Patient With AF Has a Previous History of Intracranial Bleeding 5 years Ago (David CW Siu, HK)
2. My Patient with AF Presents with An Acute Coronary Syndrome and Needs a Sten (Razali Omar, Malaysia)
3. My Patient with New-Onset AF and CHADS2-VASc=1 (Eric Prystowsky, USA)
4. My Patient Gets a Thromboembolic Event Despite Well Controlled Warfarin (Tatjana Potpara , Serbia)
5. My Patient on Oral Anticoagulation Needs an Ablation (Jeff Healey, Canada)
4-Oct 16:00 - 17:40 Hall 5G, Rm A Session 2 - Meet the Experts: Using CHA2DS2-VASc and HAS-BLED in Everyday Clinical Practice Chairpersons: Bernard MY Cheung (Hong Kong), Yoshio Kosakai (Japan), Kok-Han Chee (Malaysia)
1. Balancing Stroke vs Bleeding Risk in the Clinic (Chern-En Chiang , Taiwan)
2. Patient with Lone Atrial Fibrillation - How "Lone" is "Lone AF"? (Stuart Thomas, Australia)
3. What the Guidelines Say (Satoshi Ogawa, Japan)
4. Is CHADS2 Score Valid in Asians? (Ru-San Tan, Singapore)
5. Use of NOAC in Practice (Paul Dorian, Canada)
5-Oct 10:40 - 12:20 Hall 5G, Rm A Session 3 - How to Use the New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Chairpersons: Suet-Ting Lau (Hong Kong), Surapun Sitthisook (Thailand), Mario Evora (Macau)
1. The Global Burden of AF – Focus on the Asian Perspective (Hung-Fat Tse, HK)
2. An Overview of the New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation (Ken Okumura, Japan)
3. What Do the Guidelines Currently Say... and What Should Future Updates Modify? (John Camm, UK)
4. Management Peri-procedure (Surgery, Devices) and Ablation (Antonio Raviele, Italy)
5. Special Situations - Ischemic Stroke and Thrombolytic, Acute Coronary Syndrome, PCI/Stent, Bridging, Cardio version etc. (Gregory Lip, UK)
5-Oct 13:50 - 15:30 Hall 5G, Rm A Session 4 - Antiarrhythmic Drugs in Atrial Fibrillation – Where are We Now? Chairpersons: Yuk-Kong Lau (Hong Kong), Choong-Hwan Kwak (Korea)
1. Do We Have Outcomes Data for Rate-control Agents? (Tze-Fan Chao, Taiwan)
2. Should We Keep Digitalis in Rate Control Armamentarium? (To be announced)
3. Is the Rate Control vs Rhythm Control Argument Shifted to Early Onset AF – EAST, RACE-3 (Isabelle van Gelder, The Netherlands)
4. Atrial Selective Anti-arrhythmia Agent: Hope or Hype? (John Camm, UK)
5. Holistic Management of AF – Looking Beyond Anti-arrhythmic Drugs (Paul Dorian, Canada) |
Ablation - VT/SVT |
3-Oct 10:40 - 12:20 Hall 5G, Rm C Session 1 - Non-infundibular Outflow Tract VT Ablation: Right and Left Chairpersons: Bo-Young Joung (Korea), Yau-Ting Tai (Hong Kong)
1. Idiopathic Ventricular Arrhythmias Arising From the Pulmonary Artery: Mapping and Ablation (Ke-Jiang Cao, China)
2. Safe and Successful Ablation of Parahisian Idiopathic Ventricular Arrhythmias (Akihiko Nogami, Japan)
3. Idiopathic Ventricular Arrhythmias Arising from the Aortic Sinuses of Valsalva: Tips and Tricks (Koji Kumagai, Japan)
4. Outflow Tract Ventricular Arrhythmia Ablation via the Coronary Venous System: Electrical and Plumbing Challenges (Haris Haqqani, Australia)
5. Epicardial Outflow Tract Arrhythmias: Percutaneous Epicardial Mapping/Ablation and Alternative Routes/Strategies (Francis E. Marchlinski, USA)
3-Oct 16:00 - 17:40 Hall 5G, Rm C Session 2 - SVT: Challenges in Bypass Tract Ablation Chairpersons: Kengo Kusano (Japan), Muhammad Yamin (Indonesia)
1. Diagnosis and Ablation of Atriofascicular Bypass Tracts: Tips and Tricks (Jonathan Kalman, Australia)
2. Catheter Ablation of Anteroseptal and Midseptal Bypass Tracts: To Burn or to Freeze? (Ngai-Yin Chan, HK)
3. Ablation of Difficult Posteroseptal Bypass Tracts: Ins and Outs (Sunny Po, USA)
4. My Most Memorable Bypass Tract Ablation Cases (Henry Hsia, USA)
5. Arrhythmic Risk in Asymptomatic WPW (George Klein, Canada)
4-Oct 08:30 - 10:10 Hall 5G, Rm B Session 3 - Nonischemic Scar-related VT Ablation Chairpersons: Beny Hartono (Indonesia)
1. Septal VT in Nonischemic Cardiomyopathy: Unipolar or Bipolar Ablation? (Vivek Reddy, USA)
2. Catheter Ablation of Ventricular Arrhythmias in Brugada Syndrome: Beyond Storm? (Koonlawee Nademanee, USA)
3. Ablation of Scar-related VT in Granulomatous Cardiomyopathy (Narasimhan Calambur, India)
4. Hybrid Approaches to Successful VT Ablation in Nonischemic Cardiomyopathy (David Callans, USA)
5. VT ablation in Valvular Cardiomyopathy: Endocardial, Epicardial and Transapical (Yan Yao, China)
4-Oct 10:40 - 12:20 Hall 5G, Rm B Session 4: Miscellaneous Topics in Scar-Related VT Ablation Chairpersons: Frank LY Tam (Hong Kong), Yuji Murakawa (Japan), Anthony King (Philippines)
1. VT Ablation in the Setting of Left Ventricular Assist Devices (David Burkhardt, USA)
2. The Role of Programmed Stimulation in 2013: Guide to ICD Placement or RFA Success? (Henry Hsia, USA)
3. Image Integration in VT Ablation: Where We Are and Where We Are Going (Alejandro Jimenez, New Zealand)
4. Role of Contact Force Sensing in VT Ablation: Pushing Harder or Smarter? (David Callans, USA)
5. VT Ablation in Repaired Tetralogy of Fallot: The Other Isthmuses (June Huh, Korea)
4-Oct 16:00 - 17:40 Hall 5G, Rm B Session 5: Ablation of Atrial Flutter Chairpersons: Yoshihide Nakamura (Japan), Daniel Tanubudi (Indonesia)
1. Diagnosis and Mapping of AFL (Rong Bai, China)
2. Non-Contact Mapping in Atypical AFL (Satoshi Higa, Japan)
3. Ablation of AFL after AF Ablation (Young-Hoon Kim, Korea)
4. Ablation of AFL Following Surgical Maze (Yasushi Miyauchi, Japan)
5. Remote Navigation for AFL Ablation (Yong-Seog Oh , Korea)
5-Oct 08:30 - 10:10 Hall 5G, Rm B Session 6 - Contemporary Topics in Idiopathic VT Ablation Chairpersons: Shu-Kin Li (Hong Kong), Takanao Mine (Japan), Narayanan Namboodiri (India)
1. Catheter Ablation of Idiopathic Fascicular VT - New Insights (Mohan Nair, India)
2. Papillary Muscle Ventricular Arrhythmia Ablation: Overcoming the Challenges (Ming-Shien Wen, Taiwan)
3. Multiple Premature Ventricular Beats: What to Do? (Eli Ovsyshcher , Israel)
4. Ectopy-Mediated Cardiomyopathy: Mechanisms and Management (Brian Olshansky , USA)
5. Ablation of Mitral and Tricuspid Annular VT: The Ventricular Rings of Fire (Hiroshi Tada, Japan)
5-Oct 13:50 - 15:30 Hall 5G, Rm B Session 7 - SVT: Diagnostic and Technical Considerations Chairpersons: Liang Chow (Hong Kong), Rohan Gunawardena (SriLanka), U-Po Lam (Macau)
1. Supraventricular Tachycardia: Diagnostic Maneuvers (Bhargava Kartikeya , India)
2. AV Node Reentrant Tachycardia: The Typical and the Atypical (Shoei K. Stephen Huang, USA)
3. Paraseptal Focal Atrial Tachycardia Ablation: Resolving Adjacent Sites of Origin (Xing-Peng Liu, China)
4. Inappropriate Sinus Tachycardia: What Role of Ablation in the Ivabradine Era? (Brian Olshansky, USA)
5. Focal Atrial Tachycardias Arising from the Appendages (Chin-Pang Chan, Hong Kong) |
Bradycardia Pacing |
3-Oct 08:30 - 10:10 Hall 5G, Rm B Session 1: Implant Related Issues in Bradycardia Pacing Chairpersons: Kai-Fat Tse (Hong Kong), Moon-Hyoung Lee (Korea)
1. Managing Anticoagulation for New Device Implants: Is there a Consensus? (Kazuo Matsumoto, Japan)
2. Non-apical RV Lead Placement for Bradycardia Support: Evidence-base and Deal Location? (Harry Mond, Australia)
3. Managing Advisories: What Should the Clinician Know About Managing Patients with Hardware Under “Advisory”? (Russell Denman, Australia)
4. Leadless Pacing: Who, What, When, Why, How? (L Bing Liem, USA)
5. How to Manage Tricuspid Regurgitation in the Device Patient with 1 or More Leads Across the Tricuspid Valve? (Ke-Ping Chen, China)
4-Oct 13:50 - 15:30 Hall 5G, Rm B Session 2: Pacemakers: Indications and Follow-Up 2013 Chairpersons: Yan Dai (China), Yih-Ling Chiou (Taiwan), Xi-Wei Deng (Macau)
1. Is Remote Monitoring for Bradycardia Devices Really Helpful? (De-Jia Huang, China)
2. Ventricular Pacing Avoidance Algorithms: When to Apply and When to Avoid (Cathy Lam, HK)
3. Programming Rate-Adaptive Sensors: Is There a Best Practice? (Hsiang-Chiang Hsiao , Taiwan)
4. Should Pacemaker Selection and Programming in the Very Elderly (> 80 years) Be Simpler? (John Fisher, USA)
5. A Pacemaker is Indicated – When Should CRT-P Be the Device of Choice? (David Hayes, USA) |
Genetic and Inherited Syndrome |
4-Oct 13:50 - 15:30 Rm 425 Session 1 - Update on Clinical Applications of Genetic Testing Chairpersons: Chiu-Sun Yue (Hong Kong), Hasri Samion (Malaysia)
1. Genotype-Phenotype Correlation in LQTS (Tohru Ohe, Japan)
2. Genetic Testing in Brugada and CPVT (Silvia Priori, Italy)
3. Genetic Testing in ARVC (Minoru Horie, Japan)
4. Genetic Testing in Sudden Unexplained Death (Chris Semsarian, Australia)
5. Key Role of Cardiac Genetic Counselling (Jodie Ingles, Australia)
5-Oct 16:00 - 17:40 Hall 5G, Rm C Session 2 - Clinical Management Cardiac Inherited Arrhythmic Syndrome Chairpersons: Nwe Nwe (Myanmar), Jitu Vohra (Australia), Chung-Seung Chiang (Hong Kong)
1. Long QT Syndrome. From Clinical Management to New Genes (Peter J. Schwartz, Italy)
2. Management of Family Members with Sudden Cardiac Death (Kui Hong , China)
3. Heart Diseases with Sodium Channel Mutation (Dao-Wu Wang, China)
4. Genetic in Cardiac Laminopathies (Saurabh Kumar, Australia)
5. Idiopathic Ventricular Fibrillation or Early Repolarization Syndrome (Masayasu Hiraoka, Japan) |
Heart Failure & Remote Patient Monitoring |
3-Oct 10:40 - 12:20 Hall 5G, Rm B Session 1 - Neuromodulation & Cardiac Arrhythmia Chairperson: Arun Chopra (India)
1. Vagal Stimulation in Man: Evidence in Heart Failure and Rationale to Prevent Lethal Arrhythmias (Peter J. Schwartz, Italy)
2. Renal Denervation to Prevent AF (Jonathan S. Steinberg, USA)
3. Spinal Cord Stimulation for Heart Failure (Hung-Fat Tse, HK)
4. Cardiac Contractility Modulation for Heart Failure (Herwig Schmidinger, Austria)
3-Oct 16:00 - 17:40 Hall 5G, Rm B Session 2 - Management of Heart Failure Patients Chairpersons: To be announced
1. Predicting Factors of LV Dysfunction in Patients with Pacemaker (Seil Oh, Korea)
2. MicroRNAs in the Diagnosis and Prognosis of Heart Failure (Hon-Chi Lee, USA)
3. Does the Remote Monitoring Reduce AF Burden and Stroke Risk in Heart Failure Patients? (Niraj Varma , USA)
4. Non-Pharmacological Approaches in Heart Failure Patients with AF (Mohammad Shenasa, USA)
5. Fundamental Approach to Arrhythmia Management in Heart Failure (Ruey Sung, Taiwan)
4-Oct 08:30 - 10:10 Hall 5G, Rm C Session 3 - Impact of Remote Monitoring in Clinical Practice Chairpersons: Wing-Hung Chui (Hong Kong), Yi-Hui Chen (Taiwan)
1. Role of Remote Monitoring to Manage Ventricular Tachyarrhythmias in Heart Failure Patients (Bernard Thibault , Canada)
2. Can Remote Monitoring of CRT Devices Help to Prevent the Occurrence of Electrical Storm in End Stage Heart Failure Patients? (Tetsuyuki Manaka, Japan)
3. Who Benefits from Hemodynamic Monitoring and CRT Optimization (Michael Gold, USA)
4. Can Remote Monitoring of CRT Devices Drive to an Earlier Cardioversion Strategy for AF Recurrences in HF Patients? (Fayez Bokhari , Saudi Arabia)
5. Remote Monitoring of Myocardial Ischemia in Heart Failure Patients (Paolo Pieragnoli, Italy)
4-Oct 16:00 - 17:40 Hall 5G, Rm C Session 4 - New Implantable Sensors: From Remote Control of Devices to Remote Control of Heart Failure Patients Chairpersons: Lawerence Wong (Hong Kong), Nam-Ho Kim (Korea), Wei-Shiang Lin (Taiwan)
1. Pulmonary Artery Sensor (Michael Gold, USA)
2. Left Atrial Pressure Sensor (Iain Melton, New Zealand)
3. Pulmonary Fluid Status (Hiroshi Tada , Japan)
4. HF Therapy Optimization Guided by Monitoring Right Ventricular Pressure (Werner Jung, Germany)
5. Respiratory Rate Trend Monitoring and Clinical Outcome (Eiichi Watanabe, Japan)
5-Oct 13:50 - 15:30 Hall 5G, Rm C Session 5 - Optimizing Benefit from CRT Chairpersons: Yu-Ho Chan (Hong Kong), Chi-Tai Kuo (Taiwan)
1. Optimization Strategies in CRT Patients (Cheuk-Man Yu , Hong Kong)
2. Novel Technologies for Targeting Left Ventricular Lead Placement (Daniel Gras, France )
3. Managing Phrenic Nerve Stimulation in CRT Patients (Tachapong Ngarmukos, Thailand)
4. Role of Acute Hemodynamic Indices to Predict Long-term Outcomes in Patients Receiving Cardiac Resynchronization Therapy (Angelo Auricchio, Switzerland)
5. CRT Response in Patients Implanted with a Quadripolar LV Lead. Are 4 Poles Better than Two? (David O'Donnell , Australia)
5-Oct 16:00 - 17:40 Rm 426 Session 6 - The Role of Devices' Remote Monitoring in Heart Failure Patients Chairpersons: Chi-Keung AuYeong (Hong Kong), Suchart Chaiyaroj (Thailand), Carolyn SP Lam (Singapore)
1. Early Detection and Management of Heart Failure Worsening by Daily Remote Monitoring of Clinical Markers (Luigi Padeletti, Italy)
2. Drug Therapy Optimization by Remote Monitoring (Masahiko Takagi, Japan)
3. Antiarrhythmic Electrical Therapy Optimization by Remote Monitoring of CRT Devices (Katherine Fan, Hong Kong)
4. Optimizing CRT Programming by Remote Monitoring (Wei Hua, China)
5. Social and Economical Sustainability of Remote Monitoring in HF: Is It Affordable for All Patients? (Niraj Varma, USA) |
Sudden Cardiac Death |
3-Oct 13:50 - 15:30 Hall 5G, Rm C Session 1 - Reduction of SCD with Device Therapy Chairpersons: Chee-Wan Lee (Singapore)
1. Subcutaneous ICD (Gust Bardy, USA)
2. CRT-D in NYHA Class I and II (David Cannom, USA)
3. CRT-D in NYHA Class III and Ambulatory IV (Wanwarang Wongcharoen, Thailand)
4. Improved ICD Programming (Peter Larsen, New Zealand)
5. Wearable Defibrillator (Morio Shoda, Japan)
4-Oct 10:40 - 12:20 Hall 5G, Rm C Session 2 - Reduction of SCD in Inherited Cardiac Disorders Chairpersons: Carmen Chan (Hong Kong), Jen-Yuan Kuo (Taiwan), Boon-Yew Tan (Singapore)
1. Long QT Syndrome (YongKeun Cho, Korea)
2. Hypertrophic Cardiomyopathy (Sumeet Chugh, USA)
3. Arrhythmogenic Right Ventricular Cardiomyopathy (Yenn-Jiang Lin, Taiwan)
4. Brugada Syndrome (Wataru Shimizu, Japan)
5. Catecholaminergic Polymorphic Ventricular Tachycardia (Silvia Priori, Italy)
5-Oct 16:00 - 17:40 Hall 5G, Rm B Session 3 - Topics in Device Programming Chairpersons: Chi-Kin Chan (Hong Kong), Preecha Uerojanaungkul (Thailand), Tak-Fu Tse (Hong Kong)
1. The PREPARE Trial (Bruce Wilkoff, USA)
2. The MADIT-RIT Trial: Trial Design and Results (Arthur Moss, USA)
3. Critique of the MADIT-RIT Trial (Jean-Jacques Blanc, France)
4. Implications of Recent Device Programming Trials for Asian Patients (Muhammad Munawar, Indonesia)
5. Implications of Recent Device Programming Trials for U.S. Patients (David Cannom, USA) |
Syncope |
3-Oct 13:50 - 15:30 Hall 5G, Rm B Session 1 - Management of Syncope Chairpersons: Xiu-Fen Qu (China), Marcellus Francis Ramirez (Philippines)
1. Paediatric Syncope: When to Worry? (Andrew Davis, Australia)
2. What is the Evidence that Drugs May Be Effective for Prevention of Vasovagal Syncope? (Andy WK Chan , Hong Kong)
3. Can We Reliably Distinguish Seizures from Syncope in the Evaluation of the ‘Collapse' Patient? (Haruhiko Abe , Japan)
4. Syncope Management Units: Do They Improve Outcomes and How Should They be Organized? (Michele Brignole, Italy)
5. New Insights Into the Role of Cardiac Pacing in Vasovagal Syncope and Is There a Best Pacing Method? (Richard Sutton , Monaco)
5-Oct 10:40 - 12:20 Hall 5G, Rm B Session 2 - Hot Topics in Syncope Chairpersons: Kin-Wing Chan (Hong Kong), Teruhisa Tanabe (Japan)
1. Causes of Transient Loss of Consciousness and Assessment of Need for Hospitalization (David Benditt , USA)
2. Syncope Unit: Impact on Patient Care and Health Related Costs (Win-Kuang Shen , USA)
3. Recent Advances in the Technology of Wearable and Insertable Cardiac Monitors and Their Clinical Outcomes in Evaluating the Collapse Patient (Laurence M. Epstein, USA)
4. Orthostatic Hypotension as a Cause of Syncope in the Elderly: How Important? And How Should We Diagnose and Manage It? (Imran Zainal Abidin, Malaysia)
5. Does Syncope Increase Risk in Patients with Suspected Channelopathy? (Philip Chang, USA) |
Tachycardia Therapy Device |
3-Oct 08:30 - 10:10 Hall 5G, Rm C Session 1 - ICD Selected Topics Chairpersons: Chi-Woon Kong (Taiwan), Boon-Yew Tan (Singapore)
1. How to Use ICD Telemetry and Pacing Response to Diagnose Tachyarrhythmias: Case Studies (Margaret Hood, New Zealand)
2. Solutions to High DFTs in 2013 (Toon-Wei Lim, Singapore)
3. When to Extract Leads Beyond the Obvious Reasons: How to Manage Recall Leads? (Peter Belott, USA)
4. ICDs in Young Patients: Indications, Challenges and Follow-up (Andrew Davis, Australia)
5. Subcutaneous ICD (Gust Bardy, USA)
4-Oct 13:50 - 15:30 Hall 5G, Rm C Session 2 - TOPICS IN CRT: Session I Chairperson: Hau-Kwong Chung (Hong Kong), Ajay Naik (India)
1. What's New on Echo and CRT Optimization in 2013? (Ivan Ho, USA)
2. Use of EKG, Intracardiacs and CXR to Get the Best Outcome for CRT at Implant (Quan Fang, China)
3. How to Get the Right CS Branch for Your LV Lead for the Best Outcome: Tools and Techniques (David O'Donnell, Australia)
4. Alternative Options for LV Lead Placement (Amit Vora, India)
5. Management of Patients Post-CRT Implant: Is It Auto-Pilot or Does It Require Tuning? (Fang Fang, Hong Kong)
5-Oct 08:30 - 10:10 Hall 5G, Rm C Session 3 - TOPICS IN CRT: Session II Chairpersons: Akira Fujiki (Japan)
1. Critical Issues in Designing a Heart Failure Trial in Asia (Carolyn Lam, Singapore)
2. The Importance of QRS Duration in a Heart Failure Trial Using CRT (Angelo Auricchio , Switzerland)
3. Possible Endpoints for a CRT Trial in Patients with Ejection Fraction 35-50% (Michael Gold, USA)
4. The MADIT Asia Trial 2013 (Arthur Moss, USA)
5. It is Safe to Implant a CRT Device with no Backup ICD in Patients with an EF 35-50% (Shu Zhang, China) |
Arrhythmias in Paediatric and Adult Congenital Heart Disease |
3-Oct 13:50 - 15:30 Rm 426 Arrhythmias in Paediatric and Adult Congenital Heart Disease Chairperson: Aldophus KT Chau (Hong Kong), Shigeru Tateno (Japan)
1. ICDs in Adult Congenital Heart Disease: Who When and How? (Tak-Cheung Yung, Hong Kong)
2. Catheter Ablation of "No Entry Heart" in Congenital Heart Disease (Morio Shoda, Japan)
3. Atypical Device Configurations in Congenital Heart Disease: Epicardial and Endocardial Systems
(Sabrina Tsao, USA)
4. Radiofrequency Catheter Ablation of Supraventricular Tachyarrhythmia in Children with Congenital Heart Disease (Shuenn-Nan Chiu, Taiwan) |
Paediatric Workshop - Paediatric Rhythm Management |
3-Oct 08:30 - 10:10 Rm 424 Session 1 - Management of Paediatric Arrhythmias I Chairperson: Shuk-Han Lee (Hong Kong), Mei-Hwan Wu (Taiwan)
1. Arrhythmias in the Failing Paediatric Heart - How to Intervene When Transplantation is Around the Corner (Sabrina Tsao, USA)
2. The Device Based Therapy for Paediatric Cardiology Population – Japanese Single Centre Experience (Aya Miyazaki, Japan)
3. How to Ablate Ventricular Tachyarrhythmias in Children without Structural Heart Disease? (Naokata Sumitomo, Japan)
4. How to Manage VT in Adult with Repaired TOF? (June Huh, Korea)
5. How to Avoid the Risk of AV Block in Children with AVNRT Ablation? (Pi-Chang Lee, Taiwan)
3-Oct 10:40 - 12:20 Rm S421 Session 2 - Management of Paediatric Arrhythmias II Chairperson: Maurice P Leung (Hong Kong), Mohit Singla (India), Pi-Chang Lee (Taiwan)
1. Ventricular Tachycardia in Children with Structurally Normal Hearts: Role of Ablation (Thomas Kriebel, Germany)
2. Management of Junctional Ectopic Tachycardia before and during TCPC Procedure in Asplenic Heart (Shigeru Tateno, Japan)
3. Radiofrequency Ablation in a Patient with WPW Syndrome with Congenital Corrected Transposition of Great Artery (Shuenn-Nan Chiu , Taiwan)
4. Electrical Storm in Paediatric Patients (Andrew Davis, Australia)
5. CRT in Patients with Congenital Heart Disease (Cesar Khazen, Austria)
4-Oct 10:40 - 12:20 Rm 425 Session 3 - Challenging Issue in the Management & Paediatric Arrhythmias Chairperson: Naokata Sumitomo (Japan)
1. Cardiac Resynchronization Therapy in Children and Congenital Heart Disease Patients (Eun-Jung Bae, Korea)
2. Challenges in Device Management: Out of the Box Settings are Inappropriate for Children (Robert Gow, Canada)
3. Transcatheter Ablation for Cardiac Arrhythmia in Congenital Heart Diseases (Ming-Chih Lin, Taiwan)
4. Risk Stratification for Asymptomatic WPW (Manoj N Obeyesekere, Australia)
5. Psychosocial Problems in Children with ICD (Elizabeth Stephenson, Canada) |
Surgical Therapy-Device and Ablation |
4-Oct 16:00 - 17:40 Rm S226 Minimally Invasive AF Surgery Chairpersons: Takashi Nitta (Japan), James Wong (Singapore)
1. Recent Progress in Minimally Invasive AF Surgery (Xu Meng, China)
2. Optimal Lesion Set in AF Surgery (Michael Yii, Australia)
3. Minimal Invasive or Total Scopic Maze Surgery (Katsuhiko Imai, Japan)
4. Totally Thoracoscopic Atrial Fibrillation Ablation (Indran Ramanathan, New Zealand) |
Joint Session: Surgery and Catheter Ablation |
5-Oct 10:40 - 12:20 Rm 429 Long-term Outcomes after AF Ablation: Catheter vs. Surgery Chairperson: Wing-Kuk Au (Hong Kong), Masataka Mitsuno (Japan)
1. Concomitant Surgical AF Ablation in Patients with High Surgical Risks Undergoing Open Heart Surgery: Risks vs. Benefits (Jae-Won Lee, Korea)
2. Anticonaglant therapy after AF Surgery (James Wong, Singapore)
3. Long-Term Outcomes after AF Surgery (Yosuke Ishii, Japan)
4. Outcome after AF Ablation (Cardiologists) (Hui-Nam Pak, Korea)
5. Outcome after AF Ablation (Cardiologists) (Teiichi Yamane, Japan) |
Basic Research |
3-Oct 08:30 - 10:10 Rm 427 Session 1: Stem Cell Therapy of Cardiac Arrhythmia Chairpersons: Huey-Ming Lo (Taiwan), Beny Hartono (Indonesia)
1. Cell-based Therapy for Treatment of Ventricular Tachyarrhythmias (Douglas Packer, USA)
2. iPSC Platform for Modeling of Inherited Dilated Cardiomyopathy (David CW Siu, Hong Kong)
3. Modeling of Inherited Channalopathy with iPSC Platform (Silvia Priori , Italy)
4. The Past and Future of Stem Cell Therapy: Toward Overcoming Arrhythmia (Hye-Jin Hwang, Korea)
5. Stem Cell Therapy for Heart Diseases: Anti-arrhythmic or Proarrhythmic (Dao-Wu Wang, China)
3-Oct 10:40 - 12:20 Rm 427 Session 2: Hot Topic on Basic Research in AF Chairpersons: Ji-Yun Wang (China), Dong-Gu Shin (Korea)
1. Tachycardia of Atrial Myocytes Induces Colagen Expression in Atrial Fibroblasts through TGF B1 (Chia-Ti Tsai, Taiwan)
2. Calcium Handling and Atrial Fibrillation (Dobromir Dobrev, Germany)
3. Micro-RNA and Atrial Fibrillation (Andreas Goette , Germany)
4. Inflammation, Fibrosis and Atrial Fibrillation (Mohammad Shenasa, USA)
5. Nervous System and Atrial Fibrillation (Shien-Fong Lin, USA)
3-Oct 13:50 - 15:30 Rm 427 Session 3: New Insights Into the Mechanism of AF I Chairpersons: Rungroj Krittayaphong (Thailand)
1. Latest Insight on the Mechanism of AF: Implication on Management (Eric Prystowsky, USA)
2. Systems Biology of Atrial Fibrillation (Andrew Grace, UK)
3. Therapeutic Potential of Ryanodine Receptor Channels in Atrial Arrhythmias (Haruo Honjo, Japan)
4. Roles of Potassium Channels in Atrial Fibrillation (Tae-Joon Cha, Korea)
5. Neural Mechanism of Atrial Fibrillation (Peng-Sheng Chen , USA)
3-Oct 16:00 - 17:40 Rm 427 Session 4: New Insights Into the Mechanism of AF II Chairpersons: Erika Maharani (Indonesia)
1. Rotational Activation in AF: Insights from Direct Contact Mapping (Dennis Lau, Australia)
2. Molecular Basis for Tachycardia-Bradycardia Syndrome (Yung-Hsin Yeh, Taiwan)
3. Intercellular Communication and Atrioventricular Conduction (Yu-Shien Ko, Taiwan)
4. Connexin and AF (Hung-I Yeh, Taiwan)
5. Mechanistic Insights into Atrial Thrombogenesis in AF (Jeff Healey, Canada)
4-Oct 13:50 - 15:30 Rm 427 Session 5: New Therapeutic Target for Treatment of AF Chairpersons: Boron CW Cheng (Hong Kong), Kee-Joon Choi (Korea), Daniel Tanubudi (Indonesia)
1. The Relationship of Adipocytokines and Potassium Channels (Kun-Tai Lee, Taiwan)
2. Use Neural Simulation to Control Atrial Fibrillation (Sunny Po, USA)
3. Epicardial Rotor Ablation for the Treatment of Atrial Fibrillation (Chung-Chuan Chou, Taiwan)
4. Optical Mapping in Atrial Fibrillation (José Jalife, USA)
5. Ultrarapid Delayed Rectifier (IKUR) and Acetylcholine-Activated Potassium Channels (IKACh) as Atrial Selective Targets for Atrial Fibrillation (Gui-Rong Li, Hong Kong)
4-Oct 16:00 - 17:40 Rm S226 Session 6: New Insights Into the Mechanism and Management of Ventricular Arrhythmias Chairpersons: Kengo Kusano (Japan), Muhammad Yamin (Indonesia)
1. A Revisit of VF Types (Tsu-Juey Wu, Taiwan)
2. Application of Biological Simulation to the Studies of Ventricular Defibrillation (Takashi Ashihara, Japan)
3. Computational Modeling for Studying Mechanisms of Arrhythmogenesis in Ion Channelopathies (Chu-Pin Lo, Taiwan)
4. Rotors and Cardiac Fibrillation (José Jalife, USA)
5. Arrhythmia Mechanisms and Treatments of Catecholaminergic Polymorphic Ventricular Tachycardia (Hiroshi Watanabe, Japan)
5-Oct 08:30 - 10:10 Rm 427 Session 7: New Insights Into the Mechanism of Ventricular Fibrillation Chairpersons: Yoshio Kosakai (Japan), Kok-Han Chee (Malaysia)
1. Systems Biology of Sudden Cardiac Death (Andrew Grace, UK)
2. Alcohol and Cardiac Arrhythmias (Chung-Lieh Hung, Taiwan)
3. Ryanodine Receptor as a New Target for Antiarrhythmic Drug Therapy (Peter Jones, New Zealand)
4. Small Conductance Calcium Activated K (SK) Channel and Cardiac Electrophysiology (Yu-Cheng Hsieh, Taiwan)
5. Proarrhythmic Consequences of SK Channel Inhibition (Peng-Sheng Chen , USA)
5-Oct 10:40 - 12:20 Rm 427 Session 8: New Insights Into the Mechanism and Management of Atrial Arrhythmias Chairpersons: Chun-Ho Cheng (Hong Kong), Azlan Hussin (Malaysia)
1. Atrial Fibrosis: A New Paradigm in AF Development and Impact on Transcatheter Ablation (Ali Oto, Turkey)
2. Electrophysiology of Omega-3 Fatty Acid to PV Cardiomyocytes (Kazuyoshi Suenari, Japan)
3. Role of Adipocytokines on Atrial Arrhythmogenesis (Yi-Jen Chen, Taiwan)
4. Obesity and Atrial Electrostructural Remodeling (Yong-Mei Cha, USA)
5. Electrical Remodeling Induced by Primary Oxidative Stress - Studies in Primary Hyperoxidative Mice Model (Shinichi Niwano, Japan)
5-Oct 16:00 - 17:40 Rm 427 Session 9: New Insights Into the Mechanism Cardiac Arrhythmias Chairpersons: Maria Belen O. Carisma (Philippines)
1. Arrhythmia Mechanisms and Treatments of Catecholaminergic Polymorphic Ventricular Tachycardia (Bjorn Knollmann , USA)
2. New Insights into the Steep Portion of the APD Restitution Curve (Yu-Cheng Hsieh, Taiwan)
3. Oxidative Stress, Glycolytic Inhibition, and Ventricular Fibrillation (Norishige Morita, Japan)
4. Protective Role of HO-1 in Atrial Fibrillation (Yung-Hsin Yeh, Taiwan)
5. Apamin-Sensitive Calcium-Activated Potassium Currents in Rabbit Ventricles with Chronic Myocardial Infarction (Young-Soo Lee, Korea) |
AF Ablation Workshop |
3-Oct 10:40 - 12:20 Rm 426 Session 1 - Long Term Follow-up of AF Ablation Chairpersons: Benjamin Jacob (India), Christian de Chillou (France), Louisa Poon (Hong Kong)
1. Long term Follow-up of Non Paroxysmal AF (Jonathan Kalman, Australia)
2. Ablation of AF without PV Isolation. What is the Long Term Follow-up? (Xue Zhao, China)
3. What to Do if PVs are Isolated at Redo Procedures? (Toshiya Kurotobi, Japan)
4. Termination of AF during Ablation of Long Standing Persistent AF Should it be the End Point? (Hui-Nam Pak, Korea)
5. Long Term Follow-up of Paroxysmal AF (Shih-Ann Chen, Taiwan)
3-Oct 16:00 - 17:40 Rm 425 Session 2 - Technologies and Tools for AF Ablation; Where DO We Stand in 2013 Chairpersons: YoungKeun On (Korea)
1. Point by Point RF Ablation with Irrigated Ablation Catheters (Wing-Hong Fung, Hong Kong)
2. Contact Sensing RF Ablation Catheters (Gerhard Hindricks , Germany)
3. Balloon Based Ablation Systems (Wyn Davies, UK)
4. Future Perspectives (Andrea Natale, USA)
5. Remote Controlled Ablation Systems (Chi-Keong Ching, Singapore)
3-Oct 16:00 - 17:40 Rm 430 Session 3 - Antithrombotic Therapy for Stroke Prevention of AF Chairpersons: Michael SH Wan (Australia), Louisa Poon (Hong Kong)
1. Antithrombotic Therapy for Stroke Prevention in AF Around Asian-Pacific Region: Have the Needs been Met ? (Li-Jen Lin, Taiwan)
2. Are Anti-Platelets Obsolete in Stroke Prevention? (David CW Siu, Hong Kong)
3. Effectiveness of Low Intensity Anticoagulation in Asian People (Chun-Yu Zeng, China)
4. Optimal Anticoagulation Strategy in Patients with High Risk of Bleeding (Bo-Young Joung, Korea)
5. Best Candidates of NOAC (Nam-Ho Kim, Korea)
4-Oct 08:30 - 10:10 Rm 425 Session 4 - AF Ablation: Special Consideration Chairpersons: Kun-Tai Lee (Taiwan), Kyoung-Min Park (Korea)
1. Indications for AF Ablation (Yun-Long Xia, China)
2. How to Apply 4D CT Imaging for AF Ablation (Hsuan-Ming Tsao, Taiwan)
3. How to Select Patients for Superior Vena Cava Ablation? (Yasuteru Yamauchi, Japan)
4. Application of NOAC for AF Ablation (Gregory Lip, UK)
5. How to Monitor and Follow-Up Patient after AF Ablation? (Wen-Chin Tsai, Taiwan)
4-Oct 10:40 - 12:20 Rm S227 Session 5 - Optimizing Outcomes of RF Catheter Ablation Chairpersons: Bien-Hsien Huang (Taiwan)
1. Techniques to Achieve Permanent PV Isolation (Yoshito Iesaka, Japan)
2. Techniques to Create and Confirm Linear LA Ablation (Meleze Hocini, France)
3. Techniques to Ablation Complex Fractionated Atrial Electrograms (Koonlawee Nademanee, USA)
4. Techniques to Map and Ablate Non PV Triggers (Ming-Long Chen, China)
5. Rotor Ablation: The FIRM Experience (Sanjiv Narayan, USA)
4-Oct 13:50 - 15:30 Rm S227 Session 6 - AF Ablation: Special Population Chairperson: Jen-Che Hsieh (Taiwan)
1. Patients with Valvular Heart Disease (Atsushi Takahashi, Japan)
2. Patients with Post-Surgery Cardiomyopathy (Fa-Bo Chung, Taiwan)
3. Patients with Chronic Renal Disease (Yoshihide Takahashi, Japan)
4. Patients with Systolic Heart Failure (Rahul Singhal, India)
5. Patients with Sleep Apnea (Prashanthan Sanders , Australia)
4-Oct 16:00 - 17:40 Rm 423 Session 7 - New Insights on the Mechanisms of AF Chairpersons: Eun-Sun Jin (Korea), Hsuan-Ming Tsao (Taiwan)
1. Neural Mechanisms of AF and Ventricular Rate (Hyung-Wook Park, Korea)
2. Atrial Refractory Period and Associated Structural Heart Disease (Jae-Sun Uhm, Korea)
3. Atrial Remodeling after Catheter Ablation of AF (Li-Wei Lo, Taiwan)
4. Atrial Electromechanical Interval Mapping in AF (Wen-Chung Yu, Taiwan)
5. Nonlinear Signal Analysis in AF (Men-Tzung Lo, Taiwan)
5-Oct 08:30 - 10:10 Rm 425 Session 8 - Practical Application of Antithrombotic Therapy in AF Chairpersons: Jiunn-Lee Lin (Taiwan), Hyung-Wook Park (Korea)
1. CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation: A Nationwide Population-Based Cohort Study (Tsu-Juey Wu, Taiwan)
2. Incidence of Silent AF after Catheter Ablation (Kazutaka Aonuma, Japan)
3. Anticoagulation in Patients Receiving Cardioversion (Johannes Brachmann, Germany)
4. Anticoagulation in Patients with Renal Dysfunction (Edmund Ang, Philippines)
5.Secondary Stroke Prevention in Atrial Fibrillation (Jyh-Hong Chen, Taiwan)
6. Overview of Anticoagulation Usage for Stroke Prevention in Asia (Kang-Ling Wang, Taiwan)
5-Oct 13:50 - 15:30 Rm 426 Session 9 - AF Ablation: Novel Insight Chairpersons: Narasimhan Calambur (India)
1. How to Improve the Durability of PVI in AF-Ablation: Advantage of Repeat ATP-Method (Teiichi Yamane, Japan)
2. Surrogating Biomarker to Predict Outcome after AF Ablation (Tae-Joon Cha , Korea)
3. Low Voltage Zone Ablation is an Effective Adjunctive Therapy after Pulmonary Vein Antrum Isolation in Patients with Electrically Damaged Left Atrium (Takeshi Tsuchiya, Japan)
4. Relationship between Epicardial Fat Location by MSCT and CFAE Ablation (Ichiro Watanabe, Japan)
5. Ganglionated Plexi Ablation plus Antral PV Isolation for AF (Kohei Yamashiro, Japan)
6-Oct 08:30 - 10:10 Rm 426 Session 10 - Challenging Cases in Catheter Ablation of AF Chairpersons: Steven SL Li (Hong Kong), Anil Saxena (India)
Case 1 - Topic to be announced (Oussama Wazni, USA)
Case 2 - The Effect of PV Isolation on the Response of Ganglionated Plexi located inside the PV Area (Shigeru Ikeguchi, Japan)
Case 3 - Cases with Complicated Atrial Tachycardia after PV Isolation, Mapping and Diagnosis (Kazuhiro Satomi, Japan)
Case 4 - AF Radiofrequency Ablation Using Conventional Ablation Catheters (Joy Maliackal Thomas , India)
6-Oct 10:40 - 12:20 Rm 426 Session 11 - What's New in AF Ablation Chairpersons: Rohan Gunawardena (Sri Lanka)
1. Anatomy for Ablation of Atrial Fibrilation (Jose Angel Cabrera, Spain)
2. Imaging Integration and 3-D Mapping for VT (Roberto De Ponti, Italy)
3. Hansen Robotic System (Andrew McGavigan, Australia)
4. Ballon Catheter Pulmonary Vein Isolation (Boris Schmidt, Germany)
5. Remote Navigation for AF Ablation (Xu Chen, Denmark)
|
VT Workshop |
3-Oct 13:50 - 15:30 Rm 424 Session 1 - Hot Topics on Ventricular Arrhythmia Chairpersons: Tak-Sun Tse (Hong Kong), Bernard Abi-Saleh (Lebanon)
1. Genetic Testing for Inherited Cardiac Disease (Arthur Wilde, The Netherlands)
2. Novel ECG Based Risk Stratification of VT & SCD (André Ng, UK)
3. Mechanisms of Ventricular Arrhythmias and Autonomic Modulation (Jason Bradfield, USA)
4. New Technology for VT Mapping(Edward P. Gerstenfeld, USA)
5. Low Energy Defibrillation for VT/VF (Jian Huang, USA)
3-Oct 16:00 - 17:40 Rm 424 Session 2 - ARVC Session Chairperson: Jason KC Ko (Hong Kong)
1. Catheter Ablation of Arrhythmias by Magnetic Navigation System in China (Ke-Jiang Cao, China)
2. Genetic and Molecular Basis of ARVC (Minoru Horie, Japan)
3. Updated Criteria for ARVC Diagnosis (Hugh Calkins, USA)
4. Current Therapies for ARVC (Kyoung-Min Park, Korea)
5. Catheter Ablation of ARVC: Updated Results (Yan Yao, China)
4-Oct 08:30 - 10:10 Rm S227 Session 3 - Structural Heart Disease VT Chairperson: Ahmed Al-Fagih (Saudi Arabia)
1. How to Decide the Exit of the Circuit - Entrainment, ECG Criteria (Kyoko Soejima, Japan)
2. How to Map-Activation, Substrate (Anees Thajudeen, India)
3. How to Ablate-Several Methods-Delayed Potential, Exit Linear Ablation etc. (Yong-Seog Oh, Korea)
4. When to Decide the Epicardial Ablation (Masaomi Chinushi, Japan)
5. Alternative Method-Surgical, Bipolar etc. (Vivek Reddy, USA)
4-Oct 13:50 - 15:30 Rm 424 Session 4 - VT in Cardiomyopathy Chairpersons: Vadagenahalli S Prakash (India), Alejandro Jimenez (New Zealand)
1. Catheter Ablation of VT in Dilated Cardiomyopathy (Masahiko Goya, Japan)
2. Epicardial Ablation in DCM (Jason Bradfield, USA)
3. Electrophysiological Characteristics and Catheter Ablation of Bundle Branch Reentrant Ventricular Tachycardia (Harumizu Sakurada, Japan)
4. Ablation of VT in ARVD (Francis E. Marchlinski, USA)
5. Ablation of VT in Hypertrophic Cardiomyopathy (Luigi Di Biase, USA)
6. Illustrative Cases of Idiopathic VT and Scar VT in DCM and ICM (Kalavakolanu Sharada, India)
5-Oct 16:00 - 17:40 Rm 424 Session 5 - Idiopathic VT Chairperson: Eli Ovsyshcher (Isreal)
1. Diagnosis and Assessment of Idiopathic VT (Vadagenahalli S Prakashvs, India)
2. Outflow Tract VT Ablation and Long-Term Outcome (Hung-Ta Wo, Taiwan)
3. Atypical Idiopathic Ventricular Tachycardia (Bobby John, India)
4. Aortic Cuspid VT from Bench to Bedside (Yash Yahya Lokhandwala, India)
5. Epicardial Ablation of Idiopathic VT (Masaomi Chinushi, Japan)
6. Potentials in the Posterior Fascicle for Ventricular Tachycardia: Active Role or Passive Bystander (Xun-Zhang Wang, USA)
6-Oct 08:30 - 19:10 Rm 424 Session 6 - Future VT Ablation Chairpersons: Ming-Shien Wen (Taiwan), Bobby John (India)
1. Future Technology for VT Ablation (Vivek Reddy, USA)
2. Advances in MRI Guided Ablation (Ganesan Anand, Australia)
3. Remote Navigation System for VT Ablation (Edward P. Gerstenfeld, USA)
4. Bundle Branch Reentry VT (Dennis Zhu, China)
5. Catheter Ablation of VT (Ischemic and Non-Ischemic VT) (Shiro Nakahara, Japan) |
CRT Workshop |
4-Oct 10:40 - 12:20 Rm 423 Session 1 - Toward Personalized Pacing Strategy Chairpersons: Yau-Ting Tai (Hong Kong)
1. Importance of Multidisciplinary Approach to CRT Patients: A Key Factor for Improved Response (Bruce Wilkoff, USA)
2. Is RV Pacing Needed for CRT or is LV-only Sufficient (David Cannom, USA)
3. Should Patients with RBBB not Considered for CRT? (Kuan-Hung Yeh, Taiwan)
4. Ablation Strategies in CRT Candidates (Sang-Weon Park, Korea)
5. Should CRT be Considered for Any Patient Requiring a Pacemaker (David Hayes, USA)
4-Oct 13:50 - 15:30 Rm 423 Session 2 - Non-responders in CRT Chairpersons: Ming-Ho Wong (Hong Kong), Toon-Wei Lim (Singapore)
1. Overview (David Hayes, USA)
2. Optimization of CRT by with Electrogram Parameter (Vince Paul , Australia)
3. Optimization of CRT by SPECT (Jian-Gang Zou, China)
4. How to Select CRT Responder (Ulhas M. Pandurangi, India)
5. Characteristics of Non-responder after CRT by Speckle-Tracking Echocardiography (Kazuhiro Tatsumi, Japan)
5-Oct 08:30 - 10:10 Rm 424 Session 3 - Challenging Cases in Patients with CEID Chairpersons: Kheng-Siang Ng (Singapore), Ashish Nabar (India)
Case 1 - Venous Anomalies during CRT Implant (Anoop Gupta, India)
Case 2 - ICD Implant in ARVD Patient with Severe RV Dilatation and Myocardial Dysfunction (Ajay Naik, India)
Case 3 - Adaptive CRT (Vanita Arora, India)
Case 4 - Simultaneous Contrast Medium Injection via Collateral Cardiac Vein to Facilitate LV Lead Implantation (Kuan-Hung Yeh, Taiwan)
Case 5 - Topic to be announced (Ryan Ko, Hong Kong)
5-Oct 16:00 - 17:40 Rm S226 Session 4 - Challenging Anatornie for Implantation Chairperson: Ping-Tim Tsui (Hong Kong)
Case 1 - Congenital Complete Heart Block Deteriorating in Left Ventricular Function Soon (with in months) after Implantation of a Permanent Pacemaker and Requiring Upgrade to a CRT Device (Ashish Nabar, India)
Case 2 - CRT Case - Options when Target Vein is Non-Usable (Mohan Nair, India)
Case 3 - Coronary sinus ostium obstruction (Jen-Che Hsieh, Taiwan)
Case 4 - Use of Snares for Difficult LV Lead Implantation (Seth Worley, USA)
6-Oct 08:30 - 10:10 Rm 425 Session 5 - 2013 Novelties Chairpersons: Yui-Chi So (Hong Kong)
1. What's New in the 2013 ESC/EHRA Guidelines? (Angelo Auricchio, Switzerland)
2. Management of Infection and Lead Issues in CRT Patients (Robert Giles , Australia)
3. Atrial Fibrillation in CRT Patients: Rate or Rhythm Control? (Bo Yu, China)
4. Remote Management of Arrhythmias and Device in CRT Patients (Tetsuyuki Manaka, Japan)
5. Multi Site or Multipoint Pacing for CRT (David O'Donnell, Australia)
6-Oct 13:50 - 15:30 Rm 425 Session 6 - Updates of CRT for Heart Failure Chairpersons: Wilson WM Chan (Hong Kong)
1. New Indication for CRT (Johannes Sperzel, Gernmany)
2. Management of AF in CRT Patients (Maurizio Gasparini, Italy)
3. Remote Monitoring of CRT Patients (Katherine Fan, Hong Kong)
4. Long-Term Complications of CRT-D (Maurizio Landolina, Italy)
5. Optimization of CRT(Bülent Özin, Turkey) |
ICD Workshop |
3-Oct 13:50 - 15:30 Rm 423 Session 1 - New Trends in ICD Management Chairperson: Kam-Sang Woo (Hong Kong)
1. The Subcutaneous Defibrillator (Bradley Knight, USA)
2. Trends in ICD Programming or “Minimizing Inappropriate Shocks” (David Hayes, USA)
3. High DFT Prediction and Management (Peter Lercher , Austria)
4. ICD Lead Extraction (Bruce Wilkoff, USA)
5. VT Storm (Spencer Heald, New Zealand)
4-Oct 16:00 - 17:40 Rm 424 Session 2 - ICD Follow-Up Chairperson: Fayez Bokhari (Saudi Arabia)
1. Detection of AF by ICDs (John Fisher, USA)
2. Management of High DFT (Jan-Yow Chen, Taiwan)
3. ICD Lead Integrity Surveillance (Chi-Wo Chan, Hong Kong)
4. Efficacy and Safety of Remote Monitoring for ICDs (Wei Hua , China)
5. Predictors and Impacts of Inappropriate ICD Shocks (Young-Keun On, Korea) |
Lead Extraction Workshop |
|
SVT Workshop |
3-Oct 08:30 - 10:10 Rm 425 Session 1: Getting Start Chairperson: Chi-Ming Tam (Hong Kong), Hasri Samion (Malaysia)
1. Differential Diagnosis of SVT (Bradley Knight, USA)
2. Ablation of Septal AP (Sunny Po, USA)
3. Ablation of Mahaim AP (Soot-Keng Ma, Malaysia)
4. Ablation of Difficult AVNRT (Mark McGuire , Australia)
5. Ablation of Atypical AVNRT (Eun-Sun Jin, Korea)
4-Oct 08:30 - 10:10 Rm 424 Session 2: Anatomy for SVT Ablation Chairperson: Soot-Keng Ma (Malaysia)
1. Specialize in Cardiac Anatomy Relating to SVT and Catheter Ablation (Osamu Igawa, Japan)
2. Novel Approach for Ablation of Mahaim Fiber (Kaoru Okishige, Japan)
3. AV Nodal Reentry Revisited: Demonstration of Possible Atrial Fusion Beats During Atrial Overdrive Pacing or Extrastimulation of AV Nodal Reentrant Tachycardia (Fumio Suzuki , Japan)
4. Multiple Mahaim Fibers (Blair Singh, India)
5. SVT in Ebstein Anomaly (Narayanan Namboodiri, India)
5-Oct 08:30 - 10:10 Rm 429 Session 3: Challenging SVT Ablation Chairpersons: Shoei K. Stephen Huang (USA), Xun-Zhang Wang (USA), Raymond HW Chan (Hong Kong)
1. Ablation of Difficult Focal AT (Gregory K. Feld, USA)
2. Ablation of Focal AT Originating from Aortic Coronary Cusp (Hyoung-Seob Park , Korea)
3. Ablation of Arrhythmias Originating from the AV Node Area (Jian-Ming Li, USA)
4. Ablation of SVT in Congenital Heart Diseases (Kai Lau, Australia)
5. Inappropriate Sinus Tachycardia and POTS: Ablative and Non-Ablative Therapies (Win-Kuang Shen, USA)
5-Oct 13:50 - 15:30 Rm 429 Session 4: Challenging SVT Ablation Chairperson: Godwin TC Leung (Hong Kong), Hong Liu (Macau)
1. Catheter Ablation of SVT Patients Guided by 3D Mapping System to Minimize X-ray Exposure (Yan Yao, China)
2. Ablation of Difficult WPW (George Klein, Canada)
3. Difficult Atrial Flutter (Henry Hsia, USA)
4. Catheter Ablation of Atrial Fibrillation (Koichiro Kumagai, Japan)
5. Macro Re-Entry AT (Shih-Lin Chang, Taiwan) |
SCD Workshop |
4-Oct 16:00 - 17:40 Rm 425 Session 1 - Early Repolarization Syndrome Chairperson: Hon-Chi Lee (USA)
1. Genetics, underlying Mechanisms, and Clinical Characteristics in Early Repolarization Syndrome (Hiroshi Watanabe , Japan)
2. Bundle Branch Block may Masks Early Repolarization Syndrome(Yoshifusa Aizawa, Japan)
3. Differentiation of Early Repolarization Syndrome, J Wave Syndrome, and Idiopathic VF (Gi-Byoung Nam , Korea)
4. Is it the Prime Time to Treat the Patients with Early Repolarization? (Naomasa Makita, Japan)
5. Genome Wide Screen for Early Repolarization(Jyh-Ming Juang, Taiwan)
5-Oct 10:40 - 12:20 Rm 424 Session 2 - Brugada Syndrome Chairperson: Ajit Kumar Valaparambil (India), Iain Melton (New Zealand)
1. Genetic and Molecular Basis of BS (Kui Hong , China)
2. How to Distinguish the Real Brugada Syndrome from J wave Syndrome (Gi-Byoung Nam, Korea)
3. Clinical and Electrocardiographic Features for Risk Assessment in Brugada Syndrome (Masahiko Takagi , Japan)
4. Mapping and Ablation of the Brugada Syndrome (Koonlawee Nademanee, USA)
5. Could Brugada Syndrome be Treated without ICD? (Shiro Kamakura, Japan) |
Pacing Workshop |
3-Oct 10:40 - 12:20 Rm 423 Session 1 - The CIED Lead: Principles, Progress and Promises Chairperson: Piya Kasemsuwan (Thailand)
1. The Early Pacemaker Lead: Memories from a Bygone Era (Harry Mond , Australia)
2. How to Make the Pacing Lead Safe for MRI (Wee-Siong Teo, Singapore)
3. The Electrode Tissue Interface: The Value of Steroid Elution (Toshiyuki Ishikawa, Japan)
4. Pacemaker Lead Fixation: Active or Passive (Giselle Gervacio, Philippines)
5. Controversies in Choice of High Voltage Lead Implantation - Small versus Large Diameter Leads (Edmund Keung, USA)
4-Oct 08:30 - 10:10 Rm 423 Session 2 - Controversies in Lead Implantation Chairperson: Chairperson: Bing Liem (USA)
1. The Status of the Leadless Electrode (David Benditt, USA)
2. Where Should We Implant the RV Lead (Ben Pang, Australia)
3. Where Should We Implant the Left Ventricular Lead? (Wei Hua, China)
4. How do We Plan and Perform Lead Replacements? (Peter Belott, USA)
5.Where Should We Implant the Right Atrial Lead? (Ruth Kam, Singapore)
4-Oct 16:00 - 17:40 Rm 426 Session 3: Special Industrial Symposium Chairperson: Byron Lee (USA)
1. Update on Industry Efforts to Create New Standardized Pre-Clinical Lead Testing (Daniel J. Cooke , USA)
2. Lead Design and Design Aspects that are Important to Know for Lead Extractors (Avi Fischer, USA)
3. Lead Connectors: New DF4 / IS4 Connector Designs (Shantanu Reddy , USA)
4. Quadripolar Left Ventricular Leads for CRT (Michael Hill, USA)
5. Design and Testing of MRI Safe Lead (Erik Trip, Germany) |
Syncope Workshop - What's New in Syncope Management? |
4-Oct 10:40 - 12:20 Rm S226 Chairperson: Luca Santini (Italy)
1. How to Diagnosis Unexplained Syncope Using Hut? (Youichi Kobayashi, Japan)
2. Are there Different Hemodynamic and Autonomic Nervous Response to Head-Up Tilt between Postural Tachycardia Syndrome and Neurally Mediated Syncope? (Koichi Mizumaki, Japan)
3. What is the Latest Guidelines, Algorithms of Management of Syncope? (Bonpei Takase, Japan)
4. Role of ILR in the Evaluation of Unexplained Syncope (June-Soo Kim , Korea)
5. Is there a Role for Pacing for Syncope? (Kuo-Hung Lin, Taiwan) |
VT Ablation Workshop |
3-Oct 08:30 - 10:10 Rm 423 Chairperson: Stephen KM Tam (Hong Kong), Anees Thajudeen (India)
1. Mapping of Ablation and Unstable VT(Jo Jo Hai, Hong Kong)
2. Catheter Ablation of Hemodynamically Unstable Ventricular Tachycardia with Mechanical Circulatory Support(Fei Lü, USA)
3. PVC and LV Diastolic Dysfunction (Venkat Tholakanahalli, USA)
4. Idiopathic VT Originating from the Noncoronary Sinus of Valsalva (Takumi Yamada , USA)
5. Intacardiac Echocardiography for the Ablation VT (Bernard Abi-Saleh, Lebanon) |
Live Transmission |
3-Oct 13:50 - 15:30 Rm S421 Biosense Webster Live Transmission - VT Ablation Chairpersons: Chu-Pak Lau (Hong Kong), Ming-Hsiung Hsieh (Taiwan) Panelists: Andrea Natale (USA), Ouyang Feifan (Germany)
3-Oct 16:00 - 17:40 Rm S421 St. Jude Medical Live Transmission - Live Transmission of Persistent AF Ablation & Renal Denervation Case Review Moderator: Steve Worthley (Australia) Chairpersons: Ming-Hsiung Hsieh (Taiwan), Joseph YS Chan (Hong Kong) Panelists: Prashanthan Sanders (Australia), Steve SL Li (Hong Kong)
4-Oct 13:50 - 15:30 Rm S421 Medtronic Live Transmission - AF Cryoballoon Moderators: Shao-Wen Liu (China), Vivek Reddy (USA) Chairpersons: Chris KY Wong (Hong Kong), Gary CP Chan (Hong Kong) Panelists: Young-Hoon Kim (Korea), Chang-Sheng Ma (China), Wyn Davies (UK)
1. Lessons Learned after 300+ Cases Cryoballoon Procedure (Marcin Kowalski , USA)
2. SUPIR Study (Vivek Reddy , USA)
4-Oct 16:00 - 17:40 Rm S421 Boston Scientific Live Transmission / Watchman Session Chairperson: Margaret Hood (New Zealand) Panelists: Andrew Grace (UK), Wee-Siong Teo (Singapore), Razali Omar (Malaysia), Hung-Fat Tse (Hong Kong), Prashanthan Sanders (Australia)
1. S-ICD Live Transmission
Panelists: Andrew Grace (UK), Wee-Siong Teo (Singapore), Hung-Fat Tse (Hong Kong), Prashanthan Sanders (Australia)
2. Watchman Video Case Presentation (Raxali Omar, Malaysia)
|
Focus Session |
3-Oct 08:30 - 10:10 Rm S421 Session 1 - Heart Failure Chairperson: Herwig Schmidinger (Austria)
Case 1: Prevention of Effective CRT by Frequent PVC (Kuo-Hung Lin, Taiwan)
Case 2: A Difficult Case to Manage Phrenic Nerve Stimulation (Jin-Long Huang, Taiwan)
Case 3: Converting a CRT Non-responder into Responder (Bernard Thibault , Canada)
4-Oct 08:30 - 10:10 Rm S421 Session 2 - Sudden Cardiac Death Chairperson: Sumeet Chugh (USA) Panelists: Mohan Nair (India), Tachapong Ngarmukos (Thailand), Jae-Min Shim (Korea)
Case 1: Cardiac Arrest Following Extensive Anterior Myocardial Infarction (Mohan Nair, India)
Case 2: Electrical Storm during Therapeutic Hypothermia (Jae-Min Shim, Korea)
Case 3: Frequent Shocks in a Patient with Implantable Defibrillator (Tachapong Ngarmukos, Thailand)
5-Oct 10:40 - 12:20 Rm S421 Session 3 - AF Ablation Complications: A Case Based Approach Chairperson: Hugh Calkins (USA)
Case 1: Atrial Flutter following AF Ablation (Differential Diagnosis and Management) (Hiroshi Nakagawa, USA)
Case 2: A Case with PV Stenosis and PV Intervention - Diagnosis and Management of PV Stenosis (Kazuhiro Satomi, Japan)
Case 3: TEE Immediately Prior to AF Ablation Revels a LA Thrombus Despite Anticoagulation with Warfarin (Anticoagulation Strategies at the Time of AF Ablation) (John Day, USA)
5-Oct 16:00 - 17:40 Rm S421 Session 4 - Stroke Prevention in Atrial Fibrillation with New Anticoagulation Drugs – Practical Management Scenarios Chairpersons: Gregory Lip (UK) Panelist: Jyh-hong Chen (Taiwan)
Case 1: The Patient at High Stroke Risk, Who Subsequently Presents with an Acute Coronary Syndrome Whilst on a New Oral Anticoagulant Drug (Jo Jo Hai, Hong Kong)
Case 2: The 50 years Female Patient with Lone AF Who Undergoes Cardioversion and Subsequently, an Ablation Procedure (Tatjana Potpara , Serbia) |
Clinical Trial Updates |
4-Oct 10:40 - 12:20 Rm S421 Chairpersons: Chu-Pak Lau (Hong Kong), Shu Zhang (China)
1. An Update on ARISTOTLE Sub-analysis of Asian Patients (Shinya Goto, Japan)
2. New Advances in Shock Reduction: Pain Free SST (David Benditt, USA)
3. MADIT-CRT - Long Term Outcome (Kenneth Stein, USA)
4. PROTECT-AF (Vivek Reddy , USA)
|
Joint Sessions with Societies |
|
Joint session with WSA |
3-Oct 08:30 - 10:10 Rm S226 Session 1 - Advances in Cardiac Pacing Chairpersons: Cathy Lam (Hong Kong), Suneet Mittal (USA)
1. The Challenges to Instituting remote Monitoring of CEID Patrents in Clinical Practise (Suneet Mrttal, USA)
2. The Leadless Pacemaker: Where are We? (Reinoud Knops , The Netherlands)
3. Device Remote Control in Patients with Paroxysmal Atrial Fibrillation: Does it Reduce Hospitalization and Stroke? (Luca Santini , Italy)
4. Multisite and Multipoint Pacing to Optimize Cardiac Resynchronization Therapy (Antonio Curnis, Italy)
|
Joint session with EHRA |
3-Oct 10:40 - 12:20 Rm S226 Session 2 - New Strategies for AF Catheter Ablation: Moving Towards Personalized Ablation? Chairpersons: Teruhisa Tanabe (Japan), Claudio Hadid (Argentina)
1. Individualized Ablation versus Standard Lesion Deployment: What's the Future? (Shih-Ann Chen, Taiwan)
2. What's the Substrate of AF and What are the Drivers? (Hans Kottkamp, Switzerland)
3. Mapping of AF and Detection of Ablation Targets I: Insights from Intraoperative Mapping (Jonathan Kalman, Australia)
4. Mapping of AF and Detection of Ablation Targets II: Insights from Catheter-Based Mapping (Feifan Ouyang, Germany)
5. Mapping of AF and Detection of Ablation Targets III: Insights from Body Surface Mapping (Yoshito Iesaka, Japan) |
Joint session with ISHNE |
3-Oct 13:50 - 15:30 Rm S226 Session 3 - Atrial Fibrillation Chairpersons: Teruhisa Tanabe (Japan), Claudio Hadid (Argentina)
1. AF Clinical Overview (Chang-Sheng Ma , China)
2. New Oral Anticoagulants (Luis Aguinaga, Argentina)
3. Antiarrhythmic Drugs (Haris Haqqani, Australia)
4. Radiofrequency Ablation (Claudio Hadid , Argentina)
5. Antiarrhythmic Drugs or Radiofrequency Ablation (Gustavo Maid, Argentina) |
Joint sessions Australia-New Zealand Sympoisum |
3-Oct 16:00 - 17:40 Rm S226 Session 4 - Ventricular Arrhythmias and SCD Symposium
1. MRI Imaging to Identify Ventricular Arrhythmia Substrate (Andrew Taylor, Australia)
2. Role of Channels in Ablation of Ventricular Arrhythmias (Kurt Roberts-Thomson, Australia)
3. SCD in Chronic Kidney Disease (Joseph Morton, Australia)
4. SCD-Risk Stratification Post Infarction: Time to Revisit? (Pramesh Kovoor, Australia)
5. Role of Genetic Evaluation in Sudden Unexplained Death and Aborted Cardiac Arrest (Jitendra Vohra, Australia) |
Joint session with Italian AIAC |
4-Oct 08:30 - 10:10 Rm S226 Session 5 Chairperson: Luigi Padeletti (Italy)
1. Women and CRT devices, favourable outcomes. Why and where are the gaps, how do we adress them? (Maurizio Lunati , Italy)
2. CRT Issues: Endocardial LV Pacing (Paolo Pieragnoli, Italy)
3. CRT in HF Patients with Preexistent or New Onset AF: Ablate the His Bundle (Gianluca Botto, Italy)
4. Syncope 2013: The Italian Approach (Fabrizio Ammirati, Italy)
5. CRT-D (Luigi Padeletti, Italy) |
Joint sessions HRS / APHRS |
5-Oct 08:30 - 10:10 Rm S421 Session 6 - Stroke Prevention in Atrial Fibrillation Chairpersons: Chu-Pak Lau (Hong Kong), Anne Gillis (Canada)
1. Is There an Optimal Risk Prediction Algorithm: CHADS2, CHA2DS2-Vasc or Other? (Gregory Lip, UK)
2. Comparing the Novel Anticoagulants – Optimal Use in Clinical Practice (Jeff Healey, Canada)
3. Oral Anticoagulant Safety and Efficacy - Effect Ethnic Background (Chern-En Chiang, Taiwan)
4. Role of Atrial Occlusion Devices (Vivek Reddy, USA)
5. Quality Measures in AF Management in 2013 (Anne Gillis, Canada)
5-Oct 13:50 - 15:30 Rm S421 Session 7 - Catheter Ablation of Atrial Fibrillation: State of the Art in 2013 Chairperson: Wee-Siong Teo (Singapore)
1. Catheter Ablation of Paroxysmal Atrial Fibrillation: Technique and Outcomes (Stuart Thomas, Australia)
2. Catheter Ablation of Long Standing Persistent Atrial Fibrillation: Is There a Consensus? (Hugh Calkins, USA)
3. Complications of AF Ablation: How Can We Avoid Them (John Day, USA)
4. Indications for AF Ablation: What Do The Guidelines Tell Us? (Jonathan Kalman, Australia)
5. Managing Anticoagulation Peri Procedure (Young-Hoon Kim, Korea) |
Joint session with SOLAECE |
5-Oct 13:50 - 15:30 Rm S226 Session 8 - Atrial Fibrillation Ablation Chaiperson: Victor KM Goh (Hong Kong)
1. Who Is a Candidate for Ablation for Atrial Fibrillation? A Guidelines-Based Approach (Guilherme Fenelon, Brazil)
2. Ablation for Atrial Fibrillation: State of the Art in 2013 (Manuel Patete, Venezuela)
3. Outstanding Questions: Current Trials and Future Directions (Mauricio Abello, Argentina)
4. Ablate and Pace for Rate Control. State of the Art (Luis Molina, Mexico)
5. Anticoagulation in the Setting of Atrial Fibrillation Ablation (Luis Aguinaga, Argentina) |
Sudden Cardiac Death Prevention in Asia |
4-Oct 16:00 - 17:40 Rm S227 Chairpersons: Ji-Yun Wang (China), Kyoungim Cho (Korea)
1. Call and Push as the Key Facilitator of Public Access Defibrillation (Hideo Mitamura, Japan)
2. Non-Invasive Markers of Risk Stratification Markers for SCDs (Takanori Ikeda, Japan)
3. Early Detection and Prediction of Cardiac Event Using Electrocardiogram and Pulse Wave Recording from Car Steering Wheel Sensors (Ajit Kumar Valaparambil, India)
4. Analysis of Electrocardiography from Automated External Defibrillator during Resuscitation of Out-of-Hospital Cardiac Arrests: From Monitoring to Prognostication (Kit Chan, Hong Kong)
5. ECG - Clinical Perspectives on Fragmented QRS Complex (fQRS) (Jin-Bae Kim, Korea) |
Sudden Cardiac Death (Global) |
3-Oct 08:30 - 10:10 Rm 426 Chairpersons: Sumeet Chugh (USA), Chu-Pak Lau (Hong Kong), Young-Hoon Kim (Korea)
Global Burden and Stand Against Out-Of-Hospital SCD
1. SCD in Korea (Young-Hoon Kim, Korea)
2. Sudden Cardiac Death in Mid-Taiwan: Insights From the THUNDER Project (Kuan-Cheng Chang , Taiwan)
3. SCD in Hong Kong (Chu-Pak Lau, Hong Kong)
4. North American Experience and Lessons from the Oregon Sudden Death Study (Sumeet Chugh, USA)
5. SCD in India (Hygriv Rao, India) |
Joint Sessions with CSPE |
3-Oct 10:40 - 12:20 Rm 424 CSPE Basic Research
Session 1 - Female and Cardiac Arrhythmia Chairpersons: Li Li (China), Ke-Ping Chen (China), Bing Liu (China), Xiu-Fen Qv (China)
1. Gender Differences in Cardiac Arrhythmias (An-Li Tang, China)
2. Is Female Gender Associated with Less Sudden Cardiac Death? Evidence and Possible Mechanism (Ke-Ping Chen, China)
3. Effect of Sex on Iron Channels (Kui Hong, China)
4. Pregnancy and Cardiac Arrhythmia (Jing Xu, China)
5. Management of Anxiety or Depression in Female Patients of Arrhythmias (Xiao-Lin Xue, China)
5-Oct 08:30 - 10:10 Rm 423 CSPE Session (Device)
Session 2 - Rotor and Arrhythmia Chairpersons: Ke-Jiang Cao (China), Xin-Chun Yang (China), Bo Yang (China), Hui-Min Chu (China)
1. Rotor Modulation – New Threshold for Atrial Fibrillation Ablation? (Jian-Zeng Dong, China)
2. Intracardiac Mapping with Basket Electrode Catheter and Rotor Modulation for Atrial Fibrillation (Hua Deng, China)
3. Simultaneous Multiple-lead Body Surface Potential Mapping and Rotor Modulation for Atrial Fibrillation (Xing-Peng Liu, China)
4. Rotor and Mechanism of Ventricular Fibrillation: Evidence from Multi-electrode Epicardial Mapping (Basic Research) (Jian Huang, China)
5. Rotor and Mechanism of Ventricular Fibrillation: Evidence from Multi-electrode Epicardial Mapping (Clinical Research) (Yi-Gang Li, China)
5-Oct 10:40 - 12:20 Rm 423 CSPE Session (EP)
Session 3 - New Technologies and New Methods Chairpersons: Yi-Gang Li (China), Yan-Sheng Ding (China), Guo-Dong Niu (China), Yun-Long Xia (China)
1. Radiofrequency Catheter with Contact Force Monitoring and Its Application in Ablation for Atrial Fibrillation (Shao-Wen Liu, China)
2. The Progress in Implantable Medical Devices (Xiao-Hong Zhou, China)
3. Application of Magnetic Resonance Imaging in Radiofrequency Catheter Ablation: State-of-the-Art (He Huang, China)
4. Renal Artery Ablation in Arrhythmia Management (Qi-Jun Shan, China)
5. Surgery for Isolated Atrial Fibrillation with Totally Thoracoscope (Zhe Zheng, China)
5-Oct 13:50 - 15:30 Rm 423 CSPE Session (Device)
Session 4 - Choices of CRT Indications Chairpersons: Yu-Tang Wang (China), Yu-Gang Dong (China), Yangang Su (China)
1. CRT and Mild-to-Moderate Heart Failure (Wei Hua, China)
2. Morphology (LBBB or non-LBBB) and Duration of QRS Complex and CRT (Fa-Rong Shen, China)
3. CRT and Pacemaker-Dependent Patients with Heart Failure - Interpretation of BLOCK HF Clinical Trial (Lin Chen, China)
4. Options of CRT and CRT-D: Risk and Benefit? (Yat-Sun Chan, Hong Kong)
5-Oct 16:00 - 17:40 Rm 423 CSPE Session (EP)
Session 5 - Considerations in ICD Implantation Chairpersons: De-Jia Huang (China), Quan Fang (China), Guang-Ping Li (China)
1. Device Selection in ICD Implantation: Single-Chamber vs. Dual-Chamber (Yan Dai, China)
2. Options of Venous Access and Pocket Position (Si-Lin Chen, China*)
3. How to Decide the Site of ICD Defibrillation Lead: Apex vs. Outflow? (Jie Fan, China)
4. Selection of ICD Defibrillation Lead: Single-Coil vs. Dual-Coil (Ming-Ho Wong, Hong Kong)
5. DFT Test in ICD Implantation: Necessary or Not? (Ta-Chuan Tuan, Taiwan) |
Arrhythmia Management for Clinicians - HRS/APHRS CRM Update |
6-Oct 08:30 - 10:10 Rm S421 Session 1 - Evaluation of the Patient with an Arrhythmia Chairperson: Chu-Pak Lau (Hong Kong), Patrick TH Ko (Hong Kong)
1. ECG Workshop I (Kathy Lee, Hong Kong)
2. ECG Workshop II (George Klein, Canada)
3. Approach to the Patient with Palpitations (Hugh Calkins, USA)
4. How to Investigate the Patient with First Onset Atrial Fibrillation (Stuart Thomas, Australia)
6-Oct 10:40 - 12:20 Rm S421 Session 2 - Management of Atrial Fibrillation Chairpersons: John Day (USA), Paul Lam (Hong Kong)
1. Rate Control of AF – What the Guidelines Tell Us (Anne Gillis, Canada)
2. Rhythm Control Choices - Practical Tips on AntiArrhythmic Drug Use and Goals of Therapy (Isabelle van Gelder, The Netherlands)
3. When Should I Recommend Novel Oral Anticoagulants(Chu-Pak Lau, Hong Kong)
4. Management of AF in 2013: Does Age Matter (Win-Kuang Shen , USA)
6-Oct 13:50 - 15:30 Rm S421 Session 3 - A Clinician's Challenge in an Asymptomatic Patient Chairpersons: Andy WK Chan (Hong Kong), Cynthia Huie (Hong Kong)
1. Silent Atrial Fibrillation (To be announced)
2. Brugada ECG (Ngai-Shing Mok, Hong Kong)
3. Frequent Atrial or Ventricular Ectopics (Jason Bradfield, USA)
4. Low Ejection Fraction and LBBB (Swee-Chong Seow, Singapore)
5. A Patient with an Implantable Cardiac Device Going to Surgery, Endoscopy or MRI (John Fisher, USA)
6-Oct 16:00 - 17:40 Rm S421 Session 4 - What was not Taught in Medical School but Got Increasingly asked by Patients Chairpersons: Wing-Hong Fung (Hong Kong), Chiu-On Pun (Hong Kong)
1. I Experience Heart Racing During Running, Am I Fit for Marathon? (André Ng, UK)
2. When Should I Undergo AF Ablation to Get a Cure? (Steve Lai, Hong Kong)
3. Practical Tips on Using Novel Oral Anticoagulation (Kai-Hang Yiu, Hong Kong)
4. Dizziness, Blackout, POTS, What's the Best Approach? (Richard Sutton, UK)
5. Emerging Cardiac Rhythm Management Therapies, What does a Non-Electrophysiologist Need to Know? (David J. Callans, USA) |
APHRS Guideline Session |
5-Oct 08:30 - 10:10 Rm S227
The Launch of the APHRS's 2013 Statement on Antithrombotic Therapy of Patients with NVAF Chairperson: Jonathan Kalman (Australia), Seow Swee-Chong (Singapore)
1. To Unify and Promote Appropriate Antithrombotic Therapies in Asia-Pacific Countries (Satoshi Ogawa, Japan)
2. How to Use Warfarin, NOAC and ASA for Different Indications (Hung-Fat Tse, Hong Kong)
3. Racial Difference in Anticoagulant Effect. Fact or False? (De-Jia Huang, China)
4. NOAC, a Saviour of Stroke Prevention in NVAF for Asia-Pacific Population?
(Martin Stiles, New Zealand)
5. Warfarin-Underuse and ASA-Overuse: Results of the APHRS Survey
(Mohan Nair, India) |
APHRS Clinical Research Session |
5-Oct 10:40 - 12:20 Rm S227 Chairpersons: Joy Maliackal Thomas (India), Mitsunori Maruyama (Japan)
1. AF (CFE and DF Mapping) (Shiro Nakahara , Japan)
2. Signal Characteristics of Fractionated Electrograms in Paroxysmal, Persistent, and Long-Lasting Persistent AF
(Yenn-Jiang Lin, Taiwan)
3. Redo and Multiple Procedure after Catheter Ablation of AF (Li-Wei Lo, Taiwan)
4. The Impact of Heterogeneous Pulmonary Vein Anatomy in Catheter Ablation of Atrial Fibrillation (Shih-Lin Chang, Taiwan)
5. Risk Factors and Predictors of New Occurrence of Atrial Fibrillation (Tze-Fan Chao, Taiwan) |
APHRS Basic Research Session |
5-Oct 13:50 - 15:30 Rm S227
New Insights Into the Mechanism and Management of Cardiac Arrhythmias Chairperson: Chi-kin Chan (Hong Kong), Wei-Shiang Lin (Taiwan)
1. Animal Models for Ventricular Arrhythmia Research (Yukiomi Tsuji , Japan)
2. Neural Remodeling in Animal Models of Cardiac Arrhythmias (Peng-Sheng Chen , USA)
3. Calcium Dynamics and the Mechanisms of Ventricular Arrhythmia (Mitsunori Maruyama , Japan)
4. Sodium Calcium Exchanger as an Antiarrhythmic Target (Chung-Chuan Chou, Taiwan)
5. Targeting Intracellular Calcium Cycling in CPVT (Ruey Sung, Taiwan)
6. Store-Overloaded-Induced Calcium Release in Ventricular Arrhythmias (Peter Jones , New Zealand) |
APHRS CEID Session |
5-Oct 16:00 - 17:40 Rm S227
Global Trends in ICD and Pacemaker Implant Chaipersons: Victor KM Goh (Hong Kong), Kohei Yamashiro (Japan)
1. Australia (Harry Mond , Australia)
2. China (Shu Zhang, China)
3. Korea (Tai-Ho Rho, Korea)
4. Taiwan (Yen-Bin Liu, Taiwan)
5. Japan (Kazuo Matsumoto, Japan)
6. Malaysia (Imran Zainal Abidin, Malaysia)
7. Hong Kong (David CW Siu, Hong Kong)
8. Singapore (Wee-Siong Teo, Singapore) |
AF Ablation Debate |
3-Oct 10:40 - 12:20 Rm 425 Chairperson: Ulhas M. Pandurangi (India)
1. RF Ablation is Safer and More Effective that Cryoballoon Ablation for Treatment of Paroxysmal AF (Pro: Robert Lemery, Canada; Con: Douglas Packer, USA)
2. The Left Atrial Appendage Should Never Be Isolated
(Pro: Karl-Heinz Kuck, Germany; Con: Andrea Natale, USA)
3. Catheter Ablation of Atrial Fibrillation Should Be Recommended as a First Line Treatment Strategy Prior to Antiarrhythmic Drug Therapy for Patients with Paroxysmal Atrial Fibrillation (Pro: Hugh Calkins, USA; Con: John Camm, USA) |
CRT Debate |
3-Oct 13:50 -15:30 Rm 425 Chairperson: Katherine Fan (Hong Kong)
1. Implantation of CRT in a Patient with Complete AV-Block? (Pro: Cheuk-man Yu, Hong Kong; Con: Anne Gillis, Canada)
2. CRT-P is the Right Device for a 75 Yrs Old Female Presenting with Idiopathic Dilated Cardiomyopathy and QRS >160 ms. (Pro: Seth Worley, USA; Con: Bradley Knight, USA) |
AF Drug Debate |
4-Oct 13:50 - 15:30 Rm 426 Chairperson: Sirin Apiyasawat (Thailand), Cyrus R Kumana (Hong Kong)
Anti-Thrombotic
1. Oral anticoagulation Should be Interrupted for Pacemaker or ICD Surgery
Pro: (Li-Qun Wu, China)
Con: (Martin Stiles, New Zealand)
2. Oral Anticoagulation Should be Interrupted for AF Ablation
Pro: (Gerhard Hindricks , Germany)
Con: (Atul Verma , Canada) |
VT Ablation Debate |
5-Oct 13:50 - 15:30 Rm 425 Chairperson: Yash Yahya Lokhandwala (India)
1. Multipolar Mapping Catheters, Multiple Access Routes, and Complete Scar Homogenization are Necessary for Successful Catheter Ablation of Post-infarct Ventricular Tachycardia
Pro: (Edward P. Gerstenfeld, USA)
Con: (Karl-Heinz Kuck , Germany)
2. Asymptomatic Patients with Very Frequent Ventricular Ectopy should Undergo Prophylactic Catheter Ablation to Prevent the Development of Cardiomyopathy
Pro: (Akihiko Nogami, Japan)
Con: (Haris Haqqani, Australia) |
SCD Debate |
5-Oct 16:00 - 17:40 Rm 425 Chairperson: Katsushige Ono (Japan)
Session 1 - Defibrillator Threshold Testing Should Be Done at the Time of ICD Implantation
1. Protagonist (Jeff Healey, USA)
2. Antagonist (Ali Oto, Turkey)
|
Tokyo-Taipei-Seoul (TTS) Joint Symposium - Gender Differences in Cardiac Arrhythmias |
5-Oct 09:00 - 12:05 Room S226 Opening Remarks Masayasu Hiraoka (Japan), Wen-Ter Lai (Taiwan), Dong-Jin Oh (Korea)
Session 1: Effects of Sex Hormones on Electrophysiological Parameters Chairpersons: Tetsushi Furukawa (Japan), Yi-Jen Chen (Taiwan)
1. Sex Hormone on Atrial Electrophysiology (Wen-Chin Tsai , Taiwan)
2. Regulation of Cardiac Repolarization by Sex Hormones (Katsushige Ono, Japan)
Session 2: Gender Differences in Atrial Arrhythmias Chairpersons: Tai-Ho Rho (Korea), Hirotsugu Atarashi (Japan), Chen-Chuan Cheng (Taiwan)
1. Gender Differences in Left Atrial Electroanatomical Remodeling and Mechanical Linkage to LV Diastolic Function in Patients with AF (Hui-Nam Pak, Korea)
2. Gender Differences of P Wave Signal Averaged Electrocardiograms: Based on the Risk of AF (Kyoungim Cho, Korea)
3. Gender Differences in Risk and Management of Atrial Arrhythmia (Tze-Fan Chao , Taiwan)
4. Gender Differences in Risk Factors of Atrial Fibrillation (Hiroshi Watanabe, Japan)
Session 3: Gender Differences in Ventricular Arrhythmias Chairpersons: Kazutaka Aonuma (Japan), You-Ho Kim (Korea)
1. Gender Difference of ST-segment and Role of Sex Hormone (Mikiko Nakagawa, Japan)
2. Gender Difference in Ventricular Tachycardia (Jo-Nan Liao , Taiwan)
Closing Remarks Hirotsugu Atarashi (Japan), Chi-Tai Kuo (Taiwan), Young-Hoon Kim (Korea)
|
* To be confirmed
|